Stem-Cell Research: Sample-to-Data Workflows for Stem-Cell and Regenerative-Medicine Research

Event Details

When

October 1, 2026 at 10:00 AM ET

Duration

30 minutes + Q&A

Cost

Free

About this Webinar

Stem cells, including amniotic epithelial cells (AECs) and adipose-derived stem cells (ADSCs), are central to regenerative medicine due to their differentiative potential and powerful immunomodulatory capacities. Rather than relying solely on direct cell transplantation, recent research highlights the critical role of stem cell paracrine signaling mediated by extracellular vesicles (EVs) and the broader secretome in suppressing inflammation, modulating immune cell activity, and accelerating tissue repair.

In this webinar, we will explore the molecular mechanisms governing stem cell-derived EV crosstalk with immune cells. We will examine how stem cell EVs drive macrophage polarization toward anti-inflammatory phenotypes and inhibit T-cell activation.

By the end of the webinar, participants will gain actionable insights into harvesting stem cell, evaluating their immunomodulatory potential, and integrating cell-free methodologies into reproducible laboratory workflows.

About the Speaker

Giuseppe Prencipe PhD

Product Manager, Norgen Biotek

Giuseppe Prencipe, Ph.D., is a Product Manager at Norgen Biotek with a background in cellular and molecular biotechnology and physiology. He has authored 17 peer-reviewed scientific publications and has extensive research experience in stem cells, immunology, and regenerative medicine.

During his academic career, he worked in multiple European research laboratories across Italy, Austria, and Spain, and participated in international collaborations. His research focused on the crosstalk between stem cells and immune cells mediated by extracellular vesicles, investigating the molecular mechanisms underlying EV-mediated cell-to-cell communication and immune regulation.

Passionate about translating science into practical solutions, Giuseppe works at the intersection of R&D and commercial strategy, helping researchers streamline workflows for nucleic acid and exosome analysis. His work focuses on making complex sample processing more efficient, reliable, and accessible for modern molecular biology applications.

FAQs

How do stem cell-derived extracellular vesicles (EVs) modulate immune responses?

Stem cell-derived EVs carry functional biomolecules (microRNAs, proteins, and lipids) that alter target cell behavior. They suppress T-cell activation, downregulate pro-inflammatory cytokines, and drive macrophage polarization from a pro-inflammatory M1 state to an anti-inflammatory, tissue-repairing M2 phenotype.

What are the main advantages of cell-free stem cell therapeutics over direct cell transplantation?

Cell-free therapies utilizing EVs, conditioned media, and secretomes mitigate major safety concerns associated with live cell therapies, such as tumorigenicity, vascular occlusion, and low survival rates post-transplantation. They offer better stability, easier storage, and scalable manufacturing while preserving paracrine repair mechanisms.

How do amniotic epithelial cells (AECs) compare to adipose-derived stem cells (ADSCs) for EV yields?

AECs and ADSCs exhibit distinct secretome profiles and plasticities. ADSCs are widely recognized for their robust yield in tissue engineering and extracellular matrix repair, whereas AEC-derived EVs are exceptionally potent in driving immune tolerance and inflammatory control due to unique immunomodulatory cargo.

What are the biggest challenges in isolating extracellular vesicles from conditioned media?

The primary bottlenecks include protein contamination, low yield, sample degradation, and batch-to-batch variability. Streamlining sample-to-data isolation requires standardized workflows that maintain vesicle integrity without interfering with downstream nucleic acid (RNA/DNA) extraction and sequencing.

Why is sample-to-data workflow optimization critical for EV biomarker discovery?

Inconsistent sample preparation leads to co-purifying serum proteins and non-vesicular nucleic acids, skewing downstream molecular data. Optimized workflows ensure high-purity EV recovery, yielding reliable microRNA and proteomic profiles essential for translational research and diagnostic assays.